Small Molecule API Market, By Type (Synthetic/Chemical, Biological), By Application (Cardiology, Oncology, Infectious Diseases, Autoimmune Diseases, Pulmonology, Dermatology, others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI480321 | Publish Date: August 2023 | No. of Pages: 168

Global Small Molecule API Market Overview

Small molecules are chemical compounds that have a molecular weight of less than 900 Dalton and are made up of two or more atoms. Around the world, socioeconomic concerns and health issues related to the incidence of chronic diseases are prioritized. This has resulted in the pharmaceutical industry's production facilities improving, which has fueled demand for active medicinal components (API). While biologics are beginning to gain traction, small molecule APIs remain the backbone of pharmaceutical development. A small active pharmaceutical ingredient (API) molecule is a low-molecular-weight chemical component. It's a chemical compound that's found in medications and biological treatments. API can also be combined with other ingredients in completed medicinal formulations. Because it is such an important component, the pharmaceutical sector has a high need for it. The molecule can be used to diagnose, treat, and prevent a variety of disorders. Small compounds can be employed as research tools to investigate biological function and as a starting point for the creation of new therapeutics. Some can block a protein's activity or cause protein-protein interactions to be disrupted. The Global Small Molecule API Market accounted for US$ 141.79 billion in 2020 and is estimated to be US$ 300.75 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global Small Molecule API Market Dynamics

Increase in demand for effective therapy for chronic disease will drive the growth of the Market

The market for small molecule API has been fueled by an increase in demand for effective therapy for chronic disease in numerous therapeutic areas. The small molecule API market is being driven by rising prevalence of diseases such as cancer, cardiovascular disease, and infections, as well as the growth of companies that manufacture small molecule APIs and the expiration of patents on top-selling medications. The small molecule API market is developing because to an increase in corporate partnerships, simple access to medication in emerging economies, and growing consumer awareness of the benefits of small molecule API. The small molecule API market is influenced by rising technological improvements in the manufacturing sector, which has resulted in a rise in the rate of generic pharmaceuticals and increased production of small molecule APIs. Furthermore, the growing elderly population, increased public knowledge of diseases and treatments, increased research and development efforts, improved healthcare infrastructure, and an increase in healthcare expenditure all benefit the small molecule API market. Furthermore, technical advancements and innovations in the small molecule API industry will provide profitable prospects in the future.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Small Molecule API Market Segmentation

 

                                                     Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Small Molecule API Market is segmented based on type, application and region.

On the basis of Type, the Global Small Molecule API Market is segmented into Synthetic/Chemical, Biological. Based on Application, the target market is segmented into Cardiology, Oncology, Infectious Diseases, Autoimmune Diseases, Pulmonology, Dermatology, others.

Regional Insights:

 

                                                                                                                                   Source: Prophecy Market Insights

                                          

 

On region the Global Small Molecule API Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The active pharmaceutical ingredient market in North America dominates the small molecule API industry, although this is changing as large pharmaceutical companies devote more resources to the innovation of biologic services. Due to more encourage generic medicine growth with costing and repayment, Europe is likely to see strong growth in the small molecule API market, with CMOs accounting for the majority of production activity and providing precise market information. China is expected to continue to be one of the most profitable markets for small molecule APIs. Aside from the rising frequency of various diseases, the Chinese market is being fueled by the construction of API manufacturing facilities. The presence of less severe waste management policies will continue to promote China's growth. Beside from this, the country's rising R&D facilities and social determination will help the Small Molecule API Market flourish. Furthermore, China has risen to the forefront of small molecule API manufacturing due to a growing focus on patient awareness and the presence of key firms.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Type- Synthetic/Chemical, and Biological

By Application– Cardiology, Oncology, Infectious Diseases, Autoimmune Diseases, Pulmonology, Dermatology, others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Small Molecule API Market report based on Product Type, Therapeutic Device, End-User and region.

Global Small Molecule API Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Small Molecule API Market Key Players

The key players operating in the small molecule API market are Albemarle Corporation, Allergan, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Lonza, Merck KGaA, Novartis AG, Pfizer Inc., Siegfried Holding AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Johnson Matthey, Gilead Sciences, Inc., Amneal Pharmaceuticals LLC, Breckenridge Pharmaceutical, Inc., LUPIN, Camber Pharmaceuticals, Inc., and BASF SE.

Global Small Molecule API Market Company Profile

  • Lupin
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Albemarle Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Aurobindo Pharma
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cambrex Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Dr. Reddy’s Laboratories Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Small Molecule API Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Autonomous Car Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Level of Automation
      • Market Snippet, By Components
      • Market Snippet, By Fuel Type
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Autonomous Cars market, By Type, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Semi-Autonomous Vehicles
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Fully-Autonomous Vehicles
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Autonomous Cars market, By Level of Automation, 2020 – 2030, (US$ Mn)
    • Overview                                                
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Level 1
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Level 2 & 3
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Autonomous Vehicle
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Autonomous Cars market, By Components, 2020 – 2030, (US$ Mn)
    • Overview                                   
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • AI
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • RADAR
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • LIDAR
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Camera
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ultrasonic Sensor
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Autonomous Cars market, By Fuel Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • ICE
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • EV
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
      •  
  9. Global Autonomous Cars market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Level of Automation, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Components, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Fuel Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Level of Automation, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Components, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Fuel Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Level of Automation, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Components, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Fuel Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Level of Automation, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Components, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Fuel Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Level of Automation, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Components, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Fuel Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
  • Volkswagen
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Daimler
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Nissan Motor
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Robert Bosch
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Continental AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cisco Systems
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Tesla
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Visteon
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Small Molecule API Market is segmented based on type, application and region.

Increase in demand for effective therapy for chronic disease is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the small molecule API market are Albemarle Corporation, Allergan, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Lonza, Merck KGaA, Novartis AG, Pfizer Inc., Siegfried Holding AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Johnson Matthey, Gilead Sciences, Inc., Amneal Pharmaceuticals LLC, Breckenridge Pharmaceutical, Inc., LUPIN, Camber Pharmaceuticals, Inc., and BASF SE